Vivos Therapeutics, Inc.盘中异动股价大跌5.25%报1.62美元

市场透视01-29

北京时间2026年01月29日23时33分，Vivos Therapeutics, Inc.（VVOS.us）股票出现异动，股价大幅下跌5.25%。截至发稿，该股报1.62美元/股，成交量1.332万股，换手率0.12%，振幅3.30%。最近的财报数据显示，该股实现营业收入6.78百万美元，净利润-5.40百万美元，每股收益-0.49美元，毛利3.55百万美元，市盈率-0.93倍。机构评级方面，在...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2607067602?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-01-29 23:33","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2607067602","market":"us","top_or_hot":-1,"title":"Vivos Therapeutics, Inc.盘中异动 股价大跌5.25%报1.62美元","media":"市场透视","content":"<div>\n<p>北京时间2026年01月29日23时33分，Vivos Therapeutics, Inc.（VVOS.us）股票出现异动，股价大幅下跌5.25%。截至发稿，该股报1.62美元/股，成交量1.332万股，换手率0.12%，振幅3.30%。最近的财报数据显示，该股实现营业收入6.78百万美元，净利润-5.40百万美元，每股收益-0.49美元，毛利3.55百万美元，市盈率-0.93倍。机构评级方面，在...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012923331497a405bd&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vivos Therapeutics, Inc.盘中异动 股价大跌5.25%报1.62美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVivos Therapeutics, Inc.盘中异动 股价大跌5.25%报1.62美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-29 23:33 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012923331497a405bd&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2026年01月29日23时33分，Vivos Therapeutics, Inc.（VVOS.us）股票出现异动，股价大幅下跌5.25%。截至发稿，该股报1.62美元/股，成交量1.332万股，换手率0.12%，振幅3.30%。最近的财报数据显示，该股实现营业收入6.78百万美元，净利润-5.40百万美元，每股收益-0.49美元，毛利3.55百万美元，市盈率-0.93倍。机构评级方面，在...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012923331497a405bd&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4196","symbol_name":"保健护理服务","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012923331497a405bd&s=b","article_id":"2607067602","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012923331497a405bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2607067602","pubTimestamp":1769700794,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2026年01月29日23时33分，Vivos Therapeutics, Inc.股票出现异动，股价大幅下跌5.25%。截至发稿，该股报1.62美元/股，成交量1.332万股，换手率0.12%，振幅3.30%。Vivos Therapeutics, Inc.股票所在的医疗器械行业中，整体跌幅为0.65%。其相关个股中，Envue Medical, Inc.、Perspective Therapeutics, Inc.、Envveno Medical Corporation涨幅较大，Envue Medical, Inc.、Nuwellis, Inc.、Movano Inc.较为活跃，换手率分别为6599.28%、55.19%、20.45%，振幅较大的相关个股有Envue Medical, Inc.、Perspective Therapeutics, Inc.、Nuwellis, Inc.，振幅分别为107.83%、22.07%、20.47%。Vivos Therapeutics, Inc.公司简介：Vivos Therapeutics Inc是一家医疗技术公司。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4196":"保健护理服务","BK4139":"生物科技","LENZ":"Therapeutics","BK4007":"制药","VVOS":"Vivos Therapeutics","BK4539":"次新股"},"translate_title":"Vivos Therapeutics, Inc. shares fell 5.25% to $1.62 during intraday changes","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1.5,"VVOS":1.5},"content_text":"北京时间2026年01月29日23时33分，Vivos Therapeutics, Inc.（VVOS.us）股票出现异动，股价大幅下跌5.25%。截至发稿，该股报1.62美元/股，成交量1.332万股，换手率0.12%，振幅3.30%。最近的财报数据显示，该股实现营业收入6.78百万美元，净利润-5.40百万美元，每股收益-0.49美元，毛利3.55百万美元，市盈率-0.93倍。机构评级方面，在所有3家参与评级的机构中，67%的券商给予买入建议，33%的券商给予持有建议，无券商给予卖出建议。Vivos Therapeutics, Inc.股票所在的医疗器械行业中，整体跌幅为0.65%。其相关个股中，Envue Medical, Inc.、Perspective Therapeutics, Inc.、Envveno Medical Corporation涨幅较大，Envue Medical, Inc.、Nuwellis, Inc.、Movano Inc.较为活跃，换手率分别为6599.28%、55.19%、20.45%，振幅较大的相关个股有Envue Medical, Inc.、Perspective Therapeutics, Inc.、Nuwellis, Inc.，振幅分别为107.83%、22.07%、20.47%。Vivos Therapeutics, Inc.公司简介：Vivos Therapeutics Inc是一家医疗技术公司。它专注于开发和商业化为睡眠呼吸障碍(SDB)患者，包括轻度至中度阻塞性睡眠呼吸暂停综合征(OSA)的患者，提供非手术、无创伤、非药物和低成本的技术。 该公司为轻度至中度阻塞性睡眠呼吸暂停综合征(OSA)的患者提供治疗，涉及定制口腔矫治器和称为Vivos系统的方案。Vivos系统是一种治疗方案，通常结合使用定制口腔矫治器和专有临床治疗方法，该治疗方法由该公司开发并由经过专门培训的牙医与该公司的医疗团队合作开具处方。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2607067602","isCrawlerRequest":true}

Vivos Therapeutics, Inc.盘中异动 股价大跌5.25%报1.62美元

精彩评论

Vivos Therapeutics, Inc.盘中异动股价大跌5.25%报1.62美元